FDA Approves Transplant Trials for Gene-Edited Pig Kidneys
The FDA will allow two biotechnology companies to run clinical trials: United Therapeutics and eGenesis. United Therapeutics Corporation will start with six patients but could grow its trial to include up to 50 individuals, while eGenesis plans to begin with three patients.
Surgeons Transplant Engineered Pig Kidney Into Fourth Patient
It was the fourth pig kidney transplant in the United States, and the first of three that will be done at Mass General as part of a new clinical trial sanctioned by the Food and Drug Administration. Two of the previous patients died shortly after the procedure, including one who was critically ill before the transplant.
The first recipient of a gene-edited pig kidney died from cardiac causes 52 days after xenotransplantation. The world's first ...
FDA clears United Therapeutics for human trials of pig-to-human kidney transplants. Trial involves gene-edited pig kidneys ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback